TOBRAMYCIN FOR INJECTION
FRESENIUS KABI CANADA LTD
Quick answers
Is there a shortage of TOBRAMYCIN FOR INJECTION in Canada?
No. There is no current shortage of TOBRAMYCIN FOR INJECTION 1.2G reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
TOBRAMYCIN INJECTION USP
SANDOZ CANADA INCORPORATED
TOBI
BGP PHARMA ULC
TOBRAMYCIN INJECTION, USP
FRESENIUS KABI CANADA LTD
TEVA-TOBRAMYCIN
TEVA CANADA LIMITED
DIN
00533688
Strength
1.2G
Dosage Form
Powder For Solution
Route
Intravenous
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from FRESENIUS KABI CANADA LTD
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
900MG · DIN 02395150
20MG · DIN 02538644
50MG · DIN 02403536
50MG · DIN 02236926
DIN 02497697
3MG · DIN 02267659
3MG · DIN 02457482
3MG · DIN 02457474
50MG · DIN 02245248
500MG · DIN 02227010
2G · DIN 02226995
250MG · DIN 02227029